Larvol Delta - AB-Science-SAannounced-that-the-United-States-Patent-Ofce-has-formally-granted-a-patent-for-methods-of-treating-metastatic-castrate-resistant-prostate-cancer-mCRPC-with-its-lead-compound-masitinib

Kinaction (masitinib) - AB Science

https://www.globenewswire.com/news-release/2026/06/17/3313680/0/en/AB-Science-patent-for-masitinib-in-the-treatment-of-metastatic-castrate-resistant-prostate-cancer-formally-granted-in-the-United-States-with-a-protection-until-2042.html

Jun 17, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next